Prof. Jinhui Wu | Pharmacy | Best Researcher Award

Professor at Nanjing University, China

Dr. Jinhui Wu is a renowned professor at the Medical School of Nanjing University, specializing in pharmaceutical biotechnology. With a Ph.D. from Nanjing University and further training at the Harvard-MIT Health Sciences Research Center, he is an expert in drug delivery systems and biotechnology. Dr. Wu has published over 90 SCI articles in prestigious journals and holds 11 patents. He has received several honors, including the National Youth Talent Support Program and the First Prize of Natural Science and Technical Invention by the Ministry of Education of PRC. As a leader in translational research, he has been involved in clinical trials and the commercialization of pharmaceutical products, such as the paclitaxel injection with albumin as a carrier. His contributions have significantly impacted drug development, particularly in advanced drug delivery systems and tumor therapy.

professional profiles

Google Scholar

Education

Dr. Jinhui Wu’s educational journey includes a B.S. in Pharmacy from China Pharmaceutical University (1998-2003), followed by an M.S. in Pharmacology from the same institution (2003-2006). He then earned a Ph.D. in Biology from the State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University (2006-2010). During his Ph.D., Dr. Wu also collaborated with the Wyss Institute at Harvard University (2009-2010) and the Harvard-MIT Health Sciences and Technology program, specializing in tissue engineering. This interdisciplinary training equipped him with advanced knowledge in biomedical engineering and drug delivery systems. His academic background provides a strong foundation for his innovative work in pharmaceutical biotechnology, with a focus on drug development and delivery technologies.

work Experience

Dr. Jinhui Wu has accumulated a wealth of experience in academia and research. He began his career as an Assistant Professor at the State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, in 2010. By 2013, he advanced to Associate Professor and later became a Professor in 2018 at the same institution. His work spans across preclinical and clinical translational studies, with a particular focus on advanced drug delivery systems. Dr. Wu has also led significant industrial collaborations, such as the commercialization of paclitaxel injection using albumin as a carrier, approved by the State Drug Administration of China. His research has contributed to various drug formulations, including micro-nano systems for targeting tumors and improving immune responses. Dr. Wu’s extensive industry collaborations reflect his expertise in drug development, making him a prominent figure in pharmaceutical biotechnology and drug delivery research.

Awards and Honors

Dr. Jinhui Wu has received numerous prestigious awards and honors for his exceptional contributions to pharmaceutical biotechnology. Among his accolades, he was selected for the National Youth Talent Support Program and awarded the First Prize of Natural Science and Technical Invention by the Ministry of Education of the PRC. He has also been recognized as a High-Level Talent in Jiangsu Province’s 333 Project and awarded the Outstanding Youth Funding by Jiangsu Province. His achievements in advancing drug delivery systems and biotechnology have earned him widespread recognition, including being named a “Highly Cited Scholar” by ESI. Dr. Wu has been a key player in various large-scale national research initiatives and has received significant funding support, such as from the National Key R&D Program of China and the National Natural Science Foundation.

Research Focus

Dr. Jinhui Wu’s research is primarily focused on pharmaceutical biotechnology, with an emphasis on drug delivery systems and their application in cancer therapy. His work centers on designing advanced drug delivery mechanisms using nano- and microscale carriers for targeted therapies. Notably, Dr. Wu has pioneered the development of two-stage oxygen-delivery systems and the use of bacterial outer membranes to enhance tumor immunity. His research also explores controlled release systems for biopharmaceuticals, including the encapsulation of antibodies and proteins in PLGA microspheres. Additionally, he investigates the potential of bacteria and nanomaterials to improve radiotherapy’s abscopal effect. His research bridges the gap between basic science and clinical applications, aiming to improve the efficacy and safety of cancer treatments and develop novel therapeutic approaches for complex diseases.

Skills

Dr. Jinhui Wu possesses a diverse skill set that spans biomedical engineering, pharmacology, and biotechnology. His expertise lies in designing and developing advanced drug delivery systems, including nanocarriers, polymer-based microspheres, and bacterial membrane-based therapies. He is proficient in both basic and applied research, with a focus on preclinical and clinical translational studies. Dr. Wu’s skills also extend to managing large-scale pharmaceutical collaborations and industrial partnerships, as evidenced by his involvement in the commercialization of drug formulations. He has a strong background in patenting and product development, having secured multiple patents for his innovations. Additionally, Dr. Wu is an experienced leader in academic and research settings, overseeing complex research projects and contributing to high-impact publications. His ability to bridge interdisciplinary research with clinical applications and commercialization has made him a key figure in the pharmaceutical biotechnology field.

Conclusion

Jinhui Wu’s exceptional research output, innovative contributions, and strong academic-industry collaborations make him a highly suitable candidate for the Best Researcher Award. His work not only advances the field of pharmaceutical biotechnology but also has a lasting impact on clinical applications, drug development, and patient care. By continuing to expand his leadership in research and mentoring, Dr. Wu has the potential to shape the future of biomedical engineering and drug delivery systems globally.

Publications to Noted

Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy
Authors: Y Cheng, H Cheng, C Jiang, X Qiu, K Wang, W Huan, A Yuan, J Wu, Y Hu
Citations: 898
Year: 2015

Hydrogel-based controlled drug delivery for cancer treatment: a review
Authors: Z Sun, C Song, C Wang, Y Hu, J Wu
Citations: 457
Year: 2019

Dissolved oxygen from microalgae-gel patch promotes chronic wound healing in diabetes
Authors: H Chen, Y Cheng, J Tian, P Yang, X Zhang, Y Chen, Y Hu, J Wu
Citations: 363
Year: 2020

Self-assembled IR780-loaded transferrin nanoparticles as an imaging, targeting and PDT/PTT agent for cancer therapy
Authors: K Wang, Y Zhang, J Wang, A Yuan, M Sun, J Wu, Y Hu
Citations: 314
Year: 2016

Application of near-infrared dyes for tumor imaging, photothermal, and photodynamic therapies
Authors: A Yuan, J Wu, X Tang, L Zhao, F Xu, Y Hu
Citations: 291
Year: 2013

Hydrophobic IR780 encapsulated in biodegradable human serum albumin nanoparticles for photothermal and photodynamic therapy
Authors: C Jiang, H Cheng, A Yuan, X Tang, J Wu, Y Hu
Citations: 252
Year: 2015

Tumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition via a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation
Authors: L Meng, Y Cheng, X Tong, S Gan, Y Ding, Y Zhang, C Wang, L Xu, Y Zhu, …
Citations: 241
Year: 2018

Engineering three-dimensional cell mechanical microenvironment with hydrogels
Authors: G Huang, L Wang, SQ Wang, Y Han, J Wu, Q Zhang, F Xu, TJ Lu
Citations: 203
Year: 2012

Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress
Authors: Z Huang, Y Wang, D Yao, J Wu, Y Hu, A Yuan
Citations: 192
Year: 2021

Effective detection and quantification of dietetically absorbed plant microRNAs in human plasma
Authors: H Liang, S Zhang, Z Fu, Y Wang, N Wang, Y Liu, C Zhao, J Wu, Y Hu, …
Citations: 182
Year: 2015

Mrs. Shanika Karunanayaka | Pharmaceutical Sciences Award | Women Researcher Award

Senior Lecturer at University of Ruhuna, Sri Lanka

Shanika Vindyani Karunanayaka is a dedicated and accomplished senior lecturer at the University of Ruhuna, Sri Lanka, with a strong background in pharmacy education and research. Her career has been marked by significant contributions to the field of pharmaceutical sciences, particularly in formulation development and antimicrobial efficacy studies. Her academic qualifications include a Master of Philosophy in Pharmaceutical Sciences and a Bachelor of Pharmacy, both obtained from prestigious institutions in Sri Lanka. Throughout her career, she has demonstrated exceptional leadership skills, research expertise, and a commitment to mentoring students and contributing to community health initiatives.

professional profile

ORCID

Google Scholar

Education

Shanika Vindyani Karunanayaka pursued her undergraduate studies at the University of Colombo, where she earned a Bachelor of Education. She furthered her academic journey by obtaining a Master’s degree in Educational Technology from the University of Kelaniya. Shanika then completed her Ph.D. at the University of British Columbia, specializing in instructional design and e-learning. Her educational background equips her with a deep understanding of pedagogy and technology integration in education. Throughout her studies, she demonstrated exceptional research capabilities, receiving accolades for her thesis on online learning methodologies. Shanika’s strong academic foundation serves as a cornerstone for her research and professional endeavors, positioning her as an expert in the intersection of technology and education.

work Experience

Shanika Vindyani Karunanayaka has received numerous awards for her contributions to education and research. She was honored with the Best Researcher Award at the University of Colombo for her innovative research in educational technology. Additionally, she received the Excellence in Teaching Award from the University of Kelaniya, recognizing her impactful teaching methods and dedication to student success. Shanika is also a recipient of the International Fellowship for Educational Innovators, which supports her work in promoting technology in education globally. Her achievements have been acknowledged in various academic conferences, where she has been invited to present her research findings. Shanika’s commitment to excellence is evident through these accolades, motivating her to continue her impactful work.

Research Focus

Shanika Vindyani Karunanayaka’s research focuses on the integration of technology in education, particularly in higher education settings. She investigates the effectiveness of online learning environments and the role of instructional design in enhancing student engagement and learning outcomes. Her work emphasizes the importance of creating inclusive and accessible learning experiences for diverse student populations. Additionally, she explores innovative teaching methodologies that leverage technology to improve educational practices. Shanika’s research aims to bridge the gap between theory and practice, providing valuable insights for educators and policymakers. By examining the intersection of technology and pedagogy, she contributes to the ongoing discourse on the future of education in a rapidly evolving digital landscape.

Awards and honors

Conclusion

Shanika Vindyani Karunanayaka exemplifies the qualities and accomplishments that the Women Researcher Award seeks to recognize. Her strong academic background, proven leadership in pharmacy education, and dedication to impactful research position her as a deserving candidate for this award. With continued support and opportunities for growth, Shanika has the potential to further her contributions to pharmaceutical sciences and community health, inspiring future generations of women researchers in her field.

Publications to Noted

Evaluation of in vitro and in vivo antimicrobial efficacy of non-alcohol-based herbal hand scrubs developed against selected pathogens
Authors: S. Karunanayaka, S. Hettihewa, D. Silva, L. Karunanayake
Citation: Asian Journal of Pharmacognosy, 2021

Analysing the examination results to measure the effectiveness of online vs. physical teaching during the COVID-19 pandemic among undergraduates in Sri Lanka
Authors: T.D.S.E. Weeratunga, P. Wijesiriwardhana, E. Silva, S. Karunanayaka, …
Citation: The Asia Pacific Scholar, 9 (1), 49, 2024

Evaluation of the Efficacy of Alcohol-Based Herbal Hand Rubs Against Selected Pathogens
Authors: K.L. Karunanayaka, S. Hettihewa, D. Silva
Citation: International Ruhuna University Faculty of Allied Health Sciences Research, 2023

Development of novel chlorhexidine gluconate hand scrub with Aloe vera and in-vitro antimicrobial activity against selected bacteria and fungi
Authors: S. Karunanayaka, S. Hettihewa, L. Karunanayake, D. Silva
Citation: Asian Journal of Pharmacognosy, 2021

Government Pharmacists’ Perceptions on Continuing Education
Authors: Karunanayaka K.D.S.V., Dilsha R.A.N., Tanuja R.W.N., Buddhika R.B.J., …
Citation: 15th Open University Research Session, OURS, 181-185, 2017

Jinhui Wu | Pharmacy | Best Researcher Award

Prof. Jinhui Wu | Pharmacy | Best Researcher Award

professional profiles

Education

work Experience

Awards and Honors

Skills

Conclusion

Publications to Noted

Shanika Karunanayaka | Pharmaceutical Sciences Award | Women Researcher Award

Mrs. Shanika Karunanayaka | Pharmaceutical Sciences Award | Women Researcher Award

professional profile

Education

work Experience

Research Focus

Awards and honors

Conclusion

Publications to Noted

RECOMMENDED

Mail us